These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1773301)

  • 41. Urinary incontinence in the elderly.
    Snustad DG; Rosenthal JT
    Am Fam Physician; 1985 Nov; 32(5):182-96. PubMed ID: 4061247
    [No Abstract]   [Full Text] [Related]  

  • 42. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial.
    Burgio KL; Locher JL; Goode PS; Hardin JM; McDowell BJ; Dombrowski M; Candib D
    JAMA; 1998 Dec; 280(23):1995-2000. PubMed ID: 9863850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxybutynin chloride combined with intermittent clean catheterization in the treatment of myelomeningocele patients.
    Mulcahy JJ; James HE; McRoberts JW
    J Urol; 1977 Jul; 118(1 Pt 1):95-6. PubMed ID: 327100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transdermal oxybutynin. A viewpoint by Michael Chancellor.
    Chancellor M
    Drugs Aging; 2003; 20(11):865-6. PubMed ID: 12964893
    [No Abstract]   [Full Text] [Related]  

  • 45. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
    Goode PS; Burgio KL; Locher JL; Umlauf MG; Lloyd LK; Roth DL
    J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of hyperhidrosis with oxybutynin.
    Schollhammer M; Misery L
    Arch Dermatol; 2007 Apr; 143(4):544-5. PubMed ID: 17438194
    [No Abstract]   [Full Text] [Related]  

  • 48. Neuropathic urinary incontinence in pediatric patients: management with artificial sphincter.
    Belloli G; Campobasso P; Mercurella A
    J Pediatr Surg; 1992 Nov; 27(11):1461-4. PubMed ID: 1479510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravesical instillation of oxybutynin in women with idiopathic detrusor instability: a randomised trial.
    Enzelsberger H; Helmer H; Kurz C
    Br J Obstet Gynaecol; 1995 Nov; 102(11):929-30. PubMed ID: 8534633
    [No Abstract]   [Full Text] [Related]  

  • 50. Transdermal oxybutynin. A viewpoint by Adrian Wagg.
    Wagg A
    Drugs Aging; 2003; 20(11):865-6. PubMed ID: 12964894
    [No Abstract]   [Full Text] [Related]  

  • 51. [Assessment of the use of oxybutynin hydrochloride (Pollakisu tablets) in the elderly].
    Uchibayashi T; Nakajima K; Nihino A; Hisazumi H
    Hinyokika Kiyo; 1991 Sep; 37(9):1077-85. PubMed ID: 1785418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary incontinence in women.
    Wilkinson E
    Nurs Times; 2006 Nov 28-Dec 4; 102(48):23-4. PubMed ID: 17193773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical effects of oxybutynin hydrochloride (Pollakis)--especially in the treatment of pollakisuria, urgency and urinary incontinence].
    Yamauchi K; Ohashi K; Osanai H; Inagaki N; Yamaguchi S; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 1990 Dec; 36(12):1485-90. PubMed ID: 2075888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of unstable bladder with oxybutynin hydrochloride. Our clinical experience in 80 cases].
    Alladio F; Arena G; Ferrando U; Pigato M; Sesia G
    Minerva Urol Nefrol; 1987; 39(4):359-62. PubMed ID: 3451374
    [No Abstract]   [Full Text] [Related]  

  • 55. Oxybutynin: a new drug with analgesic and anticholinergic properties.
    Diokno AC; Lapides J
    J Urol; 1972 Aug; 108(2):307-9. PubMed ID: 5047425
    [No Abstract]   [Full Text] [Related]  

  • 56. Lack of effect of cholinergic blocking and alpha-adrenergic stimulation on nocturnal incontinence after ileocaecal bladder replacement. A controlled randomised study.
    Jakobsen H; Steven K
    Br J Urol; 1989 Apr; 63(4):379-83. PubMed ID: 2653555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of oxybutynin hydrochloride in the treatment of primary dysmenorrhea].
    Piato S; Delascio D
    Matern Infanc (Sao Paulo); 1968; 27(2):95-101. PubMed ID: 5746834
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Schaefer W
    Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621
    [No Abstract]   [Full Text] [Related]  

  • 59. Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
    Zát'ura F; Vsetica J; Abadías M; Pavlík I; Schraml P; Brod'ák M; Villoria J; Sust M;
    Eur Urol; 2010 Jan; 57(1):145-52. PubMed ID: 19446951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxybutynin for diabetic complications.
    Chideckel EW
    JAMA; 1990 Dec; 264(23):2994. PubMed ID: 2243424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.